Role of ATRX in chromatin structure and function: Implications for chromosome instability and human disease

Reproduction

Volumn 142, Issue 2, 2011, Pages 221-234

  De La Fuente, Rabindranath ^a   Baumann, Claudia ^a   Viveiros, Maria M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA THALASSEMIA MENTAL RETARDATION X LINKED PROTEIN; ATR PROTEIN; UNCLASSIFIED DRUG;

ALPHA THALASSEMIA; ALPHA THALASSEMIA MENTAL RETARDATION X SYNDROME; CANCER GROWTH; CARCINOGENESIS; CENTROMERE; CHROMATIN STRUCTURE; CHROMOSOMAL INSTABILITY; DISEASE SEVERITY; DNA MODIFICATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC MARKER; GENOMIC INSTABILITY; GONADAL DYSGENESIS; HETEROCHROMATIN; HUMAN; MALIGNANT TRANSFORMATION; MOLECULAR DYNAMICS; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TELOMERE; TRANSCRIPTION REGULATION; TROPHOBLAST; X CHROMOSOME INACTIVATION; X LINKED MENTAL RETARDATION;

ALPHA-THALASSEMIA; ANIMALS; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL INSTABILITY; DISEASE PROGRESSION; DNA HELICASES; EPIGENESIS, GENETIC; FEMALE; FRAGILE X SYNDROME; GENETIC DISEASES, X-LINKED; HETEROCHROMATIN; HUMANS; MALE; MENTAL RETARDATION, X-LINKED; NUCLEAR PROTEINS; X CHROMOSOME INACTIVATION;

MAMMALIA; MURINAE; MUS;

EID: 79960619676     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-10-0380     Document Type: Review

References (153)

1. Agrelo R & Wutz A 2009 X inactivation and disease. Seminars in Cell & Developmental Biology 21 194-200. (doi:10.1016/j.semcdb.2009.09.017)
2. Agrelo R, Souabni A, Novatchkova M, Haslinger C, Leeb M, Komnenovic V, Kishimoto H, Gresh L, Kohwi-Shigematsu T, Kenner L et al. 2009 SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells. Developmental Cell 16 507-516. (doi:10.1016/j.devcel.2009.03.006)
3. Argentaro A, Yang J, Chapman L, Kowalczyk M, Gibbons R, Higgs D, Neuhaus D & Rhodes D 2007 Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX. PNAS 104 11939-11944. (doi:10.1073/pnas.0704057104)
4. Augui S, Filion GJ, Huart S, Nora E, Guggiari M, Maresca M, Stewart AF & Heard E 2007 Sensing X chromosome pairs before X inactivation via a novel X-pairing region of the Xic. Science 318 1632-1636. (doi:10.1126/science. 1149420)
5. Bacher CP, Guggiari M, Brors B, Augui S, Clerc P, Avner P, Eils R & Heard E 2006 Transient colocalization of X-inactivation centres accompanies the initiation of X inactivation. Nature Cell Biology 8 293-299. (doi:10.1038/ncb1365)
6. Badens C, Martini N, Courrier S, DesPortes V, Touraine R, LevyN & Edery P 2006 ATRX syndrome in a girl with a heterozygous mutation in the ATRX Zn finger domain and a totally skewed X-inactivation pattern. American Journal of Medical Genetics. Part A 140 2212-2215. (doi:10.1002/ajmg.a.31400)
7. Bagheri-Fam S, Argentaro A, Svingen T, Combes AN, Sinclair AH, Koopman P & Harley VR 2011 Defective survival of proliferating Sertoli cells and androgen receptor function in a mouse model of the ATR-X syndrome. Human Molecular Genetics 20 2213-2224. (doi:10.1093/hmg/ddr109)
8. Baker LA, Allis CD & Wang GG 2008 PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 647 3-12. (doi:10.1016/j.mrfmmm.2008.07.004)
9. Banaszynski LA, Allis CD & Lewis PW 2010 Histone variants in metazoan development. Developmental Cell 19 662-674. (doi:10.1016/j.devcel.2010.10.014)
10. Barakat TS, Jonkers I, Monkhorst K & Gribnau J 2010 X-changing information on X inactivation. Experimental Cell Research 316 679-687. (doi:10.1016/j.yexcr.2010.01.015)
11. Baumann C & De La Fuente R 2009 ATRX marks the inactive X chromosome (Xi) in somatic cells and during imprinted X chromosome inactivation in trophoblast stem cells. Chromosoma 118 209-222. (doi:10.1007/s00412-008-0189-x)
12. Baumann C, Schmidtmann A, Muegge K & De La Fuente R 2008 Association of ATRX with pericentric heterochromatin and the Y chromosome of neonatal mouse spermatogonia. BMC Molecular Biology 9 29. (doi:10.1186/1471-2199-9-29)
13. Baumann C, Viveiros MM & De La Fuente R 2010 Loss of maternal ATRX results in centromere instability and aneuploidy in the mammalian oocyte and pre-implantation embryo. PLoS Genetics 6 e1001137. (doi:10.1371/journal.pgen. 1001137)
14. Berletch J, Yanf F & Disteche C 2010 Escape from X inactivation in mice and humans. Genome Biology 11 213. (doi:10.1186/gb-2010-11-6-213)
15. Bernardino J, Lombard M, Niveleau A & Dutrillaux B 2000 Common methylation characteristics of sex chromosomes in somatic and germ cells from mouse, lemur and human. Chromosome Research 8 513-525. (doi:10.1023/A: 1009271706488)
16. Bernstein E, Duncan EM, Masui O, Gil J, Heard E & Allis CD 2006 Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin. Molecular and Cellular Biology 26 2560-2569. (doi:10.1128/MCB.26.7.2560-2569.2006)
17. Bérubé N, Smeenk C & Picketts D 2000 Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. Human Molecular Genetics 9 539-547. (doi:10.1093/hmg/9.4.539)
18. Bérubé NG, Jagla M, Smeenk CA, De Repentigny Y, Kothary R & Picketts DJ 2002 Neurodevelopmental defects resulting from ATRX overexpression in transgenic mice. Human Molecular Genetics 11 253-261. (doi:10.1093/hmg/11.3.253)
19. Bérubé NG, Mangelsdorf M, Jagla M, Vanderluit J, Garrick D, Gibbons RJ, Higgs DR, Slack RS & Picketts DJ 2005 The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis. Journal of Clinical Investigation 115 258-267. (doi:10.1172/JCI22329)
20. Blewitt ME, Gendrel A-V, Pang Z, Sparrow DB, Whitelaw N, Craig JM, Apedaile A, Hilton DJ, Dunwoodie SL, Brockdorff N et al. 2008 SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivation. Nature Genetics 40 663-669. (doi:10.1038/ng.142)
21. Boggs BA, Cheung P, Heard E, Spector DL, Chinault AC & Allis CD 2002 Differentially methylated forms of histone H3 show unique association patterns with inactive human X chromosomes. Nature Genetics 30 73-76. (doi:10.1038/ng787)
22. Borsani G, Tonlorenzi R, Simmler MC, Dandolo L, Arnaud D, Capra V, Grompe M, Pizzuti A, Muzny D, Lawrence C et al. 1991 Characterization of a murine gene expressed from the inactive X chromosome. Nature 351 325-329. (doi:10.1038/351325a0)
23. Boulard M, Storck S, Cong R, Pinto R, Delage H & Bouvet P 2010 Histone variant macroH2A1 deletion in mice causes female-specific steatosis. Epigenetics & Chromatin 3 8. (doi:10.1186/1756-8935-3-8)
24. Brockdorff N 2002 X-chromosome inactivation: closing in on proteins that bind Xist RNA. Trends in Genetics 18 352-358. (doi:10.1016/S0168-9525(02)02717- 8)
25. Brockdorff N, Ashworth A, Kay GF, Cooper P, Smith S, McCabe VM, Norris DP, Penny GD, Patel D & Rastan S 1991 Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. Nature 351 329-331. (doi:10.1038/351329a0)
26. Brockdorff N, Ashworth A, Kay GF, McCabe VM, Norris DP, Cooper PJ, Swift S & Rastan S 1992 The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell 71 515-526. (doi:10.1016/0092-8674(92)90519-I)
27. Brown CJ & Willard HF 1994 The human X-inactivation centre is not required for maintenance of X-chromosome inactivation. Nature 368 154-156. (doi:10.1038/368154a0)
28. Brown CJ, Lafreniere RG, Powers VE, Sebastio G, Ballabio A, Pettigrew AL, Ledbetter DH, Levy E, Craig IW &Willard HF 1991 Localization of the X inactivation centre on the human X chromosome in Xq13. Nature 349 82-84. (doi:10.1038/349082a0)
29. Brown CJ, Hendrich BD, Rupert JL, Lafreniere RG, Xing Y, Lawrence J & Willard HF 1992 The human XIST gene: analysis of a 17 kb inactive X-specificRNAthat containsconserved repeats and is highly localizedwithin the nucleus. Cell 71 527-542. (doi:10.1016/0092-8674(92)90520-M)
30. Burgoyne PS, Mahadevaiah SK & Turner JM 2007 The management of DNA double-strand breaks in mitotic G(2), and in mammalian meiosis viewed from a mitotic G(2) perspective. BioEssays 29 974-986. (doi:10.1002/bies.20639)
31. Chadwick BP & Willard HF 2004 Multiple spatially distinct types of facultative heterochromatin on the human inactive X chromosome. PNAS 101 17450-17455. (doi:10.1073/pnas.0408021101)
32. Chang S & Brown C 2010 Identification of regulatory elements flanking human XIST reveals species differences. BMC Molecular Biology 11 20. (doi:10.1186/1471-2199-11-20)
33. Chaumeil J, Le Baccon P,Wutz A & Heard E 2006 A novel role for Xist RNA in the formation of a repressive nuclear compartment into which genes are recruited when silenced. Genes and Development 20 2223-2237. (doi:10.1101/gad.380906)
34. Chow JC, Ciaudo C, Fazzari MJ, Mise N, Servant N, Glass JL, Attreed M, Avner P, Wutz A, Barillot E et al. 2010 LINE-1 activity in facultative heterochromatin formation during X chromosome inactivation. Cell 141 956-969. (doi:10.1016/j.cell.2010.04.042)
35. Clemson CM, McNeil JA,Willard HF & Lawrence JB 1996 XIST RNA paints the inactive X chromosome at interphase: evidence for a novel RNA involved in nuclear/chromosome structure. Journal of Cell Biology 132 259-275. (doi:10.1083/jcb.132.3.259)
36. Clerc P & Avner P 2003 Multiple elements within the Xic regulate random X inactivation in mice. Seminars in Cell & Developmental Biology 14 85-92. (doi:10.1016/S1084-9521(02)00140-4)
37. Columbaro M, Capanni C, Mattioli E, Novelli G, Parnaik V, Squarzoni S, Maraldi N & Lattanzi G 2005 Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment. Cellular and Molecular Life Sciences 62 2669-2678. (doi:10.1007/s00018-005-5318-6)
38. Costanzi C, Stein P, Worrad DM, Schultz RM & Pehrson JR 2000 Histone macroH2A1 is concentrated in the inactive X chromosome of female preimplantation mouse embryos. Development 127 2283-2289. (Pubitemid 30386568)
39. Csankovszki G, Nagy A & Jaenisch R 2001 Synergism of Xist RNA, DNA methylation, and histone hypoacetylation in maintaining X chromosome inactivation. Journal of Cell Biology 153 773-784. (doi:10.1083/jcb.153.4.773)
40. Davis P & Brachmann R 2003 Chromatin remodeling and cancer. Cancer Biology & Therapy 2 24-31.
41. Deakin J, Chaumeil J, Hore T & Marshall Graves J 2009 Unravelling the evolutionary origins of X chromosome inactivation in mammals: insights from marsupials and monotremes. Chromosome Research 17 671-685. (doi:10.1007/s10577- 009-9058-6)
42. De La Fuente R, Viveiros M, Wigglesworth K & Eppig J 2004 ATRX, a member of the SNF2 family of helicase/ATPases, is required for chromosome alignment and meiotic spindle organization in metaphase II stage mouse oocytes. Developmental Biology 272 1-14. (doi:10.1016/j.ydbio.2003.12.012)
43. Dhayalan A, Tamas R, Bock I, Tattermusch A, Dimitrova E, Kudithipudi S, Ragozin S & Jeltsch A 2011 The ATRX-ADD domain binds to H3 tail peptides and reads the combinedmethylation state of K4 and K9. Human Molecular Genetics 20 2195-2203. (doi:10.1093/hmg/ddr107)
44. Drane P, Ouararhni K, Depaux A, Shuaib M & Hamiche A 2010 The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes and Development 24 1253-1265. (doi:10.1101/gad.566910)
45. Elsasser SJ, Allis CD & Lewis PW 2011 New epigenetic drivers of cancers. Science 331 1145-1146. (doi:10.1126/science.1203280)
46. Eskeland R, Leeb M, Grimes GR, Kress C, Boyle S, SproulD, GilbertN, Fan Y, Skoultchi AI, Wutz A et al. 2010 Ring1B compacts chromatin structure and represses gene expression independent of histone ubiquitination. Molecular Cell 38 452-464. (doi:10.1016/j.molcel.2010.02.032)
47. Fang J, Chen T, Chadwick B, Li E & Zhang Y 2004 Ring1b-mediated H2A ubiquitination associates with inactive X chromosomes and is involved in initiation of X inactivation. Journal of Biological Chemistry 279 52812-52815. (doi:10.1074/jbc.C400493200)
48. Feinberg AP, Ohlsson R & Henikoff S 2006 The epigenetic progenitor origin of human cancer. Nature Reviews. Genetics 7 21-33. (doi:10.1038/nrg1748)
49. Ganesan S, Silver DP, Greenberg RA, Avni D, Drapkin R, Miron A, Mok SC, Randrianarison V, Brodie S, Salstrom J et al. 2002 BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell 111 393-405. (doi:10.1016/S0092-8674(02)01052-8)
50. Garrick D, Samara V, McDowell TL, Smith AJ, Dobbie L, Higgs DR & Gibbons RJ 2004 A conserved truncated isoform of the ATR-X syndrome protein lacking the SWI/SNF-homology domain. Gene 326 23-34. (doi:10.1016/j.gene.2003. 10.026)
51. Garrick D, Sharpe JA, Arkell R, Dobbie L, Smith AJ,Wood WG, Higgs DR & Gibbons RJ 2006 Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues. PLoS Genetics 2 e58. (doi:10.1371/journal.pgen.0020058)
52. Gibbons RJ & Higgs DR 2000 Molecular-clinical spectrum of the ATR-X syndrome. American Journal of Medical Genetics 97 204-212. (doi:10.1002/1096- 8628(200023)97:3〈204::AID-AJMG1038〉3.0.CO;2-X)
53. Gibbons RJ, Picketts DJ, Villard L & Higgs DR 1995 Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). Cell 80 837-845. (doi:10.1016/0092-8674(95) 90287-2)
54. Gibbons R, Bachoo S, Picketts D, Aftimos S, Asenbauer B, Bergoffen J, Berry S, Dahl N, Fryer A, Keppler K et al. 1997 Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain. Nature Genetics 17 146-148. (doi:10.1038/ng1097-146)
55. Gibbons RJ, McDowell TL, Raman S, O'Rourke DM, Garrick D, Ayyub H & Higgs DR 2000 Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nature Genetics 24 368-371. (doi:10.1038/74191)
56. Gibbons RJ, Pellagatti A, Garrick D, Wood WG, Malik N, Ayyub H, Langford C, Boultwood J, Wainscoat JS & Higgs DR 2003 Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the [alpha]-thalassemia myelodysplasia syndrome (ATMDS). Nature Genetics 34 446-449. (doi:10.1038/ng1213)
57. Gibbons R, Wada T, Fisher C, Malik N, Mitson M, Steensma D, Fryer A, Goudie D, Krantz I & Traeger-Synodinos J 2008 Mutations in the chromatin-associated protein ATRX. Human Mutation 29 796-802. (doi:10.1002/humu.20734)
58. Goldberg AD, Banaszynski LA, Noh K-M, Lewis PW, Elsaesser SJ, Stadler S, Dewell S, Law M, Guo X, Li X et al. 2010 Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140 678-691. (doi:10.1016/j.cell.2010.01.003)
59. Gregg C, Zhang J, Butler JE, Haig D & Dulac C 2010a Sex-specific parent-of-origin allelic expression in the mouse brain. Science 329 682-685. (doi:10.1126/science.1190831)
60. Gregg C, Zhang J, Weissbourd B, Luo S, Schroth GP, Haig D & Dulac C 2010b High-resolution analysis of parent-of-origin allelic expression in the mouse brain. Science 329 643-648. (doi:10.1126/science.1190830)
61. Haas P, Roy NBA, Gibbons R, Deville M, Fisher C, Schwabe M, Bissé E, Dorsselaer A, Higgs D & Lubbert M 2009 The role of X-inactivation in the gender bias of patients with acquired alpha-thalassaemia and myelodysplastic syndrome (ATMDS). British Journal of Haematology 144 538-545. (doi:10.1111/j.1365-2141.2008.07505.x)
62. Hall LL, Byron M, Sakai K, Carrel L, Willard HF & Lawrence JB 2002 An ectopic human XIST gene can induce chromosome inactivation in postdifferentiation human HT-1080 cells. PNAS 99 8677-8682. (doi:10.1073/pnas. 132468999)
63. Hall LL, Byron M, Butler J, Becker KA, Nelson A, Amit M, Itskovitz-Eldor J, Stein J, Stein G, Ware C et al. 2008 X-inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected. Journal of Cellular Physiology 216 445-452. (doi:10.1002/jcp.21411)
64. Hall LL, Byron M, Pageau G & Lawrence JB 2009 AURKB-mediated effects on chromatin regulate binding versus release of XIST RNA to the inactive chromosome. Journal of Cell Biology 186 491-507. (doi:10.1083/jcb.200811143)
65. Heard E & Disteche CM 2006 Dosage compensation in mammals: finetuning the expression of the X chromosome. Genes and Development 20 1848-1867. (doi:10.1101/gad.1422906)
66. Heard E, Rougeulle C, Arnaud D, Avner P, Allis CD & Spector DL 2001 Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation. Cell 107 727-738. (doi:10.1016/S0092-8674(01)00598-0)
67. Helbig R & Fackelmayer FO 2003 Scaffold attachment factor A (SAF-A) is concentrated in inactive X chromosome territories through its RGG domain. Chromosoma 112 173-182. (doi:10.1007/s00412-003-0258-0)
68. Hellman A & Chess A 2007 Gene body-specific methylation on the active X chromosome. Science 315 1141-1143. (doi:10.1126/science.1136352)
69. Hendrich BD, Brown CJ & Willard HF 1993 Evolutionary conservation of possible functional domains of the human and murine XIST genes. Human Molecular Genetics 2 663-672. (doi:10.1093/hmg/2.6.663)
70. Hernandez-Munoz I, Lund AH, van der Stoop P, Boutsma E, Muijrers I, Verhoeven E, Nusinow DA, Panning B, Marahrens Y & van Lohuizen M 2005 Stable X chromosome inactivation involves the PRC1 polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase. PNAS 102 7635-7640. (doi:10.1073/pnas.0408918102)
71. Ishov AM, Vladimirova OV & Maul GG 2004 Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX. Journal of Cell Science 117 3807-3820. (doi:10.1242/jcs.01230)
72. Jeppesen P & Turner BM 1993 The inactive X chromosome in female mammals is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for gene expression. Cell 74 281-289. (doi:10.1016/0092-8674(93)90419-Q)
73. Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, Schulick RD, Tang LH, Wolfgang CL, Choti MA et al. 2011 DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331 1199-1203. (doi:10.1126/science.1200609)
74. Jonkers I, Barakat TS, Achame EM, Monkhorst K, Kenter A, Rentmeester E, Grosveld F, Grootegoed JA & Gribnau J 2009 RNF12 is an X-encoded dose-dependent activator of X chromosome inactivation. Cell 139 999-1011. (doi:10.1016/j.cell.2009.10.034)
75. Kanduri C, Whitehead J & Mohammad F 2009 The long and the short of it: RNA-directed chromatin asymmetry in mammalian X-chromosome inactivation. FEBS Letters 583 857-864. (doi:10.1016/j.febslet.2009.02.004)
76. Kawakami T, Zhang C, Taniguchi T, Kim CJ, Okada Y, Sugihara H, Hattori T, Reeve AE, Ogawa O & Okamoto K 2004 Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells. Oncogene 23 6163-6169. (doi:10.1038/sj.onc.1207808)
77. Kernohan KD, Jiang Y, Tremblay DC, Bonvissuto AC, Eubanks JH, Mann MRW & Berube NG 2010 ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain. Developmental Cell 18 191-202. (doi:10.1016/j.devcel.2009.12.017)
78. Kim M, Mauro S, Gevry N, Lis J & Kraus W 2004 NAD(+)-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 119 803-814. (doi:10.1016/j.cell.2004.11.002)
79. + into a nuclear signal. Genes and Development 19 1951-1967. (doi:10.1101/gad.1331805)
80. Law MJ, Lower KM, Voon HPJ, Hughes JR, Garrick D, Viprakasit V, Mitson M, De Gobbi M, Marra M, Morris A et al. 2010 ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner. Cell 143 367-378. (doi:10.1016/j.cell.2010.09.023)
81. Lee JT 2009 Lessons from X-chromosome inactivation: long ncRNA as guides and tethers to the epigenome. Genes and Development 23 1831-1842. (doi:10.1101/gad.1811209)
82. Lee JT & Jaenisch R 1997 The (epi)genetic control of mammalian X-chromosome inactivation. Current Opinion in Genetics&Development 7 274-280. (doi:10.1016/S0959-437X(97)80138-4)
83. Lee JT & Lu N 1999 Targeted mutagenesis of Tsix leads to nonrandom X inactivation. Cell 99 47-57. (doi:10.1016/S0092-8674(00)80061-6)
84. Lee JT,DavidowLS&WarshawskyD1999 Tsix, a gene antisense to Xist at the X-inactivation centre. Nature Genetics 21 400-404. (doi:10.1038/7734)
85. Lengner CJ, Gimelbrant AA, Erwin JA, Cheng AW, Guenther MG, Welstead GG, Alagappan R, Frampton GM, Xu P, Muffat J et al. 2010 Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 141 872-883. (doi:10.1016/j.cell.2010.04.010)
86. Lewis PW, Elsaesser SJ, Noh K-M, Stadler SC & Allis CD 2010 Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. PNAS 107 14075-14080. (doi:10.1073/pnas.1008850107)
87. Lyon MF 1961 Gene action in the X-chromosome of the mouse. Nature 190 372-373. (doi:10.1038/190372a0)
88. Mahadevaiah SK, Royo H, VandeBerg JL, McCarrey JR, Mackay S & Turner JMA 2009 Key features of the X inactivation process are conserved between marsupials and eutherians. Current Biology 19 1478-1484. (doi:10.1016/j.cub. 2009.07.041)
89. Mak W, Baxter J, Silva J, Newall AE, Otte AP & Brockdorff N 2002 Mitotically stable association of polycomb group proteins eed and enx1 with the inactive x chromosome in trophoblast stem cells. Current Biology 12 1016-1020. (doi:10.1016/S0960-9822(02)00892-8)
90. Marahrens Y, Panning B, Dausman J, Strauss W & Jaenisch R 1997 Xist-deficient mice are defective in dosage compensation but not spermatogenesis. Genes and Development 11 156-166. (doi:10.1101/gad.11.2.156)
91. Marks H, Chow JC, Denissov S, Francoijs K-J, Brockdorff N, Heard E & Stunnenberg HG 2009 High-resolution analysis of epigenetic changes associated with X inactivation. Genome Research 19 1361-1373. (doi:10.1101/gr.092643.109)
92. McDowell TL, Gibbons RJ, Sutherland H, O'Rourke DM, Bickmore WA, Pombo A, Turley H, Gatter K, Picketts DJ & Buckle VJ 1999 Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes. PNAS 96 13983-13988. (doi:10.1073/pnas. 96.24.13983)
93. Ménissier de Murcia J, Ricoul M, Tartier L, Niedergang C, Huber A, Dantzer F, Schreiber V, Amé J, Dierich A, LeMeur M et al. 2003 Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO Journal 22 2255-2263. (doi:10.1093/emboj/ cdg206)
94. Migeon BR 2006 The role of X inactivation and cellular mosaicism in women's health and sex-specific diseases. Journal of the American Medical Association 295 1428-1433. (doi:10.1001/jama.295.12.1428)
95. Migeon BR 2008 X inactivation, female mosaicism, and sex differences in renal diseases. Journal of the American Society of Nephrology 19 2052-2059. (doi:10.1681/ASN.2008020198)
96. Migeon BR, Luo S, Stasiowski BA, Jani M, Axelman J, Van Dyke DL, Weiss L, Jacobs PA, Yang-Feng TL & Wiley JE 1993 Deficient transcription of XIST from tiny ring X chromosomes in females with severe phenotypes. PNAS 90 12025-12029. (doi:10.1073/pnas.90.24.12025)
97. Moens P, Kolas N, Tarsounas M, Marcon E, Cohen P & Spyropoulos B 2002 The time course and chromosomal localization of recombination-related proteins at meiosis in the mouse are compatible with models that can resolve the early DNA-DNA interactions without reciprocal recombination. Journal of Cell Science 115 1611-1622. (Pubitemid 34520591)
98. Mohandas T, Sparkes R & Shapiro L 1981 Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science 211 393-396. (doi:10.1126/science.6164095)
99. Muers MR, Sharpe JA, Garrick D, Sloane-Stanley J, Nolan PM, Hacker T, Wood WG, Higgs DR & Gibbons RJ 2007 Defining the cause of skewed X-chromosome inactivation in X-linked mental retardation by use of a mouse model. American Journal of Human Genetics 80 1138-1149. (doi:10.1086/518369)
100. Nan X, Hou J, Maclean A, Nasir J, Lafuente MJ, Shu X, Kriaucionis S & Bird A 2007 Interaction between chromatin proteinsMECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. PNAS 104 2709-2714. (doi:10.1073/pnas.0608056104)
101. de Napoles M, Mermoud JE, Wakao R, Tang YA, Endoh M, Appanah R, Nesterova TB, Silva J, Otte AP, Vidal M et al. 2004 Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation. Developmental Cell 7 663-676. (doi:10.1016/j.devcel.2004.10.005)
102. Naughton C, Sproul D, Hamilton C & Gilbert N 2010 Analysis of active and inactive X chromosome architecture reveals the independent organization of 30 nm and large-scale chromatin structures. Molecular Cell 40 397-409. (doi:10.1016/j.molcel.2010.10.013)
103. Navarro P, Chambers I, Karwacki-Neisius V, Chureau C, Morey C, Rougeulle C & Avner P 2008 Molecular coupling of Xist regulation and pluripotency. Science 321 1693-1695. (doi:10.1126/science.1160952)
104. Ng K, Pullirsch D, Leeb M & Wutz A 2007 Xist and the order of silencing. EMBO Reports 8 34-39. (doi:10.1038/sj.embor.7400871)
105. Nguyen DK & Disteche CM 2006 Dosage compensation of the active X chromosome in mammals. Nature Genetics 38 47-53. (doi:10.1038/ng1705)
106. Nusinow DA, Hernandez-Munoz I, Fazzio TG, Shah GM, Kraus WL & Panning B 2007 Poly(ADP-ribose) polymerase 1 is inhibited by a histone H2A variant, MacroH2A, and contributes to silencing of the inactive X chromosome. Journal of Biological Chemistry 282 12851-12859. (doi:10.1074/jbc.M610502200)
107. Ogawa Y & Lee JT 2003 Xite, X-inactivation intergenic transcription elements that regulate the probability of choice. Molecular Cell 11 731-743. (doi:10.1016/S1097-2765(03)00063-7)
108. Okamoto I & Heard E 2009 Lessons from comparative analysis of X-chromosome inactivation in mammals. Chromosome Research 17 659-669. (doi:10.1007/s10577-009-9057-7)
109. Okamoto I, Patrat C, Thepot D, Peynot N, Fauque P, Daniel N, Diabangouaya P, Wolf J, Renard J, Duranthon V et al. 2011 Eutherian mammals use diverse strategies to initiate X-chromosome inactivation during development. Nature 472 370-374. (doi:10.1038/nature09872)
110. O'Neill LP, Keohane AM, Lavender JS, McCabe V, Heard E, Avner P, Brockdorff N & Turner BM 1999 A developmental switch in H4 acetylation upstream of Xist plays a role in X chromosome inactivation. EMBO Journal 18 2897-2907. (doi:10.1093/emboj/18.10.2897)
111. Ouararhni K, Hadj-Slimane R, Ait-Si-Ali S, Robin P, Mietton F, Harel-Bellan A, Dimitrov S & Hamiche A 2006 The histone variant mH2A1.1 interferes with transcription by down-regulating PARP-1 enzymatic activity. Genes and Development 20 3324-3336. (doi:10.1101/gad.396106)
112. Pageau GJ, Hall LL, Ganesan S, Livingston DM & Lawrence JB 2007 The disappearing Barr body in breast and ovarian cancers. Nature Reviews. Cancer 7 628-633. (doi:10.1038/nrc2172)
113. Pan Y & Sawalha AH 2009 Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. Translational Research 153 4-10. (doi:10.1016/j.trsl.2008.10.007)
114. Pandey RR, Mondal T, Mohammad F, Enroth S, Redrup L, Komorowski J, Nagano T, Mancini-Dinardo D & Kanduri C 2008 Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Molecular Cell 32 232-246. (doi:10.1016/j.molcel.2008.08.022)
115. Patrat C, Okamoto I, Diabangouaya P, Vialon V, Le Baccon P, Chow J & Heard E 2009 Dynamic changes in paternal X-chromosome activity during imprinted X-chromosome inactivation in mice. PNAS 106 5198-5203. (doi:10.1073/pnas. 0810683106)
116. Payer B & Lee JT 2008 X chromosome dosage compensation: how mammals keep the balance. Annual Review of Genetics 42 733-772. (doi:10.1146/annurev. genet.42.110807.091711)
117. Picketts DJ, Higgs DR, Bachoo S, Blake DJ, Quarrell OW & Gibbons RJ 1996 ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome. Human Molecular Genetics 5 1899-1907. (doi:10.1093/hmg/5.12.1899)
118. Picketts DJ, Tastan AO, Higgs DR & Gibbons RJ 1998 Comparison of the human and murine ATRX gene identifies highly conserved, functionally important domains. Mammalian Genome 9 400-403. (doi:10.1007/s003359900781)
119. Plath K, Fang J, Mlynarczyk-Evans SK, Cao R,Worringer KA,Wang H, de la Cruz CC, Otte AP, Panning B & Zhang Y 2003 Role of histone H3 lysine 27 methylation in X inactivation. Science 300 131-135. (doi:10.1126/science. 1084274)
120. Plath K, Talbot D, Hamer KM, Otte AP, Yang TP, Jaenisch R & Panning B 2004 Developmentally regulated alterations in polycomb repressive complex 1 proteins on the inactive X chromosome. Journal of Cell Biology 167 1025-1035. (doi:10.1083/jcb.200409026)
121. Pullirsch D, Haertel R, Kishimoto H, Leeb M, Steiner G &Wutz A 2010 The Trithorax group protein Ash2l and Saf-A are recruited to the inactive X chromosome at the onset of stable X inactivation. Development 137 935-943. (doi:10.1242/dev.035956)
122. Raymond FL 2006 X linked mental retardation: a clinical guide. Journal of Medical Genetics 43 193-200. (doi:10.1136/jmg.2005.033043)
123. Rens W, Wallduck MS, Lovell FL, Ferguson-Smith MA & Ferguson-Smith AC 2010 Epigenetic modifications on X chromosomes in marsupial and monotreme mammals and implications for evolution of dosage compensation. PNAS 107 17657-17662. (doi:10.1073/pnas.0910322107)
124. Ritchie K, Seah C, Moulin J, Issac C, Dick F & Berube NG 2008 Loss of ATRX leads to chromosome cohesion and congression defects. Journal of Cell Biology 180 315-324. (doi:10.1083/jcb.200706083)
125. Rougeulle C, Chaumeil J, Sarma K, Allis CD, Reinberg D, Avner P & Heard E 2004 Differential histone H3 Lys-9 and Lys-27 methylation profiles on the X chromosome. Molecular and Cellular Biology 24 5475-5484. (doi:10.1128/MCB.24.12.5475-5484.2004)
126. Serrano E, Lasa A, Perea G, Carnicer M, Brunet S, Aventín A, Sierra J & Nomdedéu J 2006 Acute myeloid leukemia subgroups identified by pathway-restricted gene expression signatures. Acta Haematologica 116 77-89. (doi:10.1159/000093636)
127. Shumaker DK, Dechat T, Kohlmaier A, Adam SA, Bozovsky MR, Erdos MR, Eriksson M, Goldman AE, Khuon S, Collins FS et al. 2006 Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging. PNAS 103 8703-8708. (doi:10.1073/pnas.0602569103)
128. Silva J, Mak W, Zvetkova I, Appanah R, Nesterova TB, Webster Z, Peters AH, Jenuwein T, Otte AP & Brockdorff N 2003 Establishment of histone h3 methylation on the inactive X chromosome requires transient recruitment of Eed-Enx1 polycomb group complexes. Developmental Cell 4 481-495. (doi:10.1016/S1534-5807(03)00068-6)
129. Silva SS, Rowntree RK, Mekhoubad S & Lee JT 2008 X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. PNAS 105 4820-4825. (doi:10.1073/pnas.0712136105)
130. Smith KP, Byron M, Clemson CM & Lawrence JB 2004 Ubiquitinated proteins including uH2A on the human and mouse inactive X chromosome: enrichment in gene rich bands. Chromosoma 113 324-335. (doi:10.1007/s00412-004-0325-1)
131. Sporn JC, Kustatscher G, Hothorn T, Collado M, Serrano M, Muley T, Schnabel P & Ladurner AG 2009 HistonemacroH2A isoforms predict the risk of lung cancer recurrence. Oncogene 28 3423-3428. (doi:10.1038/onc.2009.26)
132. Stavropoulos N, Rowntree RK & Lee JT 2005 Identification of developmentally specific enhancers for Tsix in the regulation of X chromosome inactivation. Molecular and Cellular Biology 25 2757-2769. (doi:10.1128/MCB.25. 7.2757-2769.2005)
133. Steensma DP, Higgs DR, Fisher CA & Gibbons RJ 2004 Acquired somatic ATRX mutations in myelodysplastic syndrome associated with {alpha} thalassemia (ATMDS) convey amore severe hematologic phenotype than germline ATRX mutations. Blood 103 2019-2026. (doi:10.1182/blood-2003-09-3360)
134. Steensma DP, Gibbons RJ & Higgs DR 2005 Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies. Blood 105 443-452. (doi:10.1182/blood-2004-07-2792)
135. Steensma DP, Porcher JC, Litzow MR, Hogan WJ, Arora S & Van Laar ES 2009 Assessment of ATRX expression in patients with myelodysplastic syndromes treated with decitabine. Leukemia Research 33 e81-e82. (doi:10.1016/j.leukres. 2008.11.030)
136. Sun BK & Tsao H 2008 X-chromosome inactivation and skin disease. Journal of Investigative Dermatology 128 2753-2759. (doi:10.1038/jid.2008.145)
137. Takagi N & Abe K 1990 Detrimental effects of two active X chromosomes on early mouse development. Development 109 189-201.
138. Tang J,Wu S, Liu H, Stratt R, Barak OG, Shiekhattar R, Picketts DJ &
139. Tang P, Park DJ, Marshall Graves JA & Harley VR 2004b ATRX and sex differentiation. Trends in Endocrinology and Metabolism 15 339-344. (doi:10.1016/j.tem.2004.07.006)
140. Tang P, Argentaro A, Pask AJ, O'Donnell L, Marshall-Graves J, Familari M & Harley VR 2011 Localisation of the chromatin remodelling protein, ATRX in the adult testis. Journal of Reproduction and Development [in press]. (doi:10.1262/jrd.20221)
141. Timinszky G, Till S, Hassa PO, Hothorn M, Kustatscher G, Nijmeijer B, Colombelli J, Altmeyer M, Stelzer EHK, Scheffzek K et al. 2009 A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation. Nature Structural & Molecular Biology 16 923-929. (doi:10.1038/nsmb.1664)
142. Trojer P & Reinberg D 2007 Facultative heterochromatin: is there a distinctive molecular signature? Molecular Cell 28 1-13. (doi:10.1016/j. molcel.2007.09.011)
143. Tulin A & Spradling A 2003 Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci. Science 299 560-562. (doi:10.1126/science.1078764)
144. Tulin A, Stewart D & Spradling AC 2002 The Drosophila heterochromatic gene encoding poly (ADP-ribose) polymerase (PARP) is required to modulate chromatin structure during development. Genes and Development 16 2108-2119. (doi:10.1101/gad.1003902)
145. Vialard F, Petit C, Bergere M, Gomes DM, Martel-Petit V, Lombroso R, Ville Y, Gerard H & Selva J 2006 Evidence of a high proportion of premature unbalanced separation of sister chromatids in the first polar bodies of women of advanced age. Human Reproduction 21 1172-1178. (doi:10.1093/humrep/dei484)
146. Villard L, Lossi AM, Cardoso C, Proud V, Chiaroni P, Colleaux L, Schwartz C & Fontés M 1997 Determination of the genomic structure of the XNP/ATRX gene encoding a potential zinc finger helicase. Genomics 43 149-155. (doi:10.1006/geno.1997.4793)
147. Vincent-Salomon A, Ganem-Elbaz C, Manié E, Raynal V, Sastre-Garau X, Stoppa-Lyonnet D, Stern M-H & Heard E 2007 X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors. Cancer Research 67 5134-5140. (doi:10.1158/0008-5472.CAN-07-0465)
148. Wang J, Mager J, Chen Y, Schneider E, Cross JC, Nagy A & Magnuson T 2001 Imprinted X inactivation maintained by a mouse Polycomb group gene. Nature Genetics 28 371-375. (doi:10.1038/ng574)
149. Wong L, McGhie J, Sim M, Anderson M, Ahn S, Hannan R, George A, Morgan KA, Mann J & Choo KH 2010 ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. Genome Research 20 351-360. (doi:10.1101/gr.101477.109)
150. Xu N, Tsai C-L & Lee JT 2006 Transient homologous chromosome pairing marks the onset of X inactivation. Science 311 1149-1152. (doi:10.1126/science. 1122984)
151. Xue Y, Gibbons R, Yan Z, Yang D, McDowell TL, Sechi S, Qin J, Zhou S, Higgs D & Wang W 2003 The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. PNAS 100 10635-10640. (doi:10.1073/pnas.1937626100)
152. Yang F, Baumann C & De La Fuente R 2009 Persistence of histone H2AX phosphorylation after meiotic chromosome synapsis and abnormal centromere cohesion in poly (ADP-ribose) polymerase (Parp-1) null oocytes. Developmental Biology 331 326-338. (doi:10.1016/j.ydbio.2009.05.550)
153. Zhang LF, Huynh KD & Lee JT 2007 Perinucleolar targeting of the inactive X during S phase: evidence for a role in the maintenance of silencing. Cell 129 693-706. (doi:10.1016/j.cell.2007.03.036)